English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
6 天
双周皮下注射 200mg 沙瑞鲁单抗,对类风湿关节炎疗效更优?
为比较 IL-6R 抑制剂疗效,研究人员开展相关队列研究,发现 SAR-SC 200mg 双周疗法效果更佳。 类风湿关节炎(rheumatoid arthritis,RA)是一种常见的自身免疫性疾病,给患者带来了极大的痛苦。在治疗 RA 的众多方法中,通过使用沙瑞鲁单抗(sarilumab,SAR)或托珠单抗 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Hits correction territory
Ordered to reinstate workers
Weekly jobless claims fall
200% tariff on EU alcohol?
Says he supports ceasefire
Plane engine catches fire
To host Golden Globes
Texas Tech closes campus
US influencer sparks outrage
FDA, NIH nominees advance
Top FDA lawyer resigns
$3B deal to extend rights
Won't block GOP bill
Exits bankruptcy protection
Trump Tower protest
Teixeira pleads guilty
Won't run for Senate in MI
UN report accuses Israel
To test Community Notes
Swatting call about gunman
Police charge stepmother
Smishing scam warning
Acne treatments recalled
Legendary sportswriter dies
States sue to block layoffs
Urges US to move nukes
Out as creative director
CDC nomination withdrawn
Asks SCOTUS to intervene
Ditch new stadium deal
IRS demotes chief counsel
反馈